GEM 21S

Welcome to the Brand page for “GEM 21S”, which is offered here for Growth factor enhanced pharmaceutical preparations for the treatment of periodontal and cranio-maxillofacial (cmf) bone and soft tissue defects, bone and tissue defects of the head, jaw, and face and related wound healing and tissue repair;.

Its status is currently believed to be active. Its class is unavailable. “GEM 21S” is believed to be currently owned by “BioMimetic Pharmaceuticals, Inc.”


Owner:
BIOMIMETIC PHARMACEUTICALS, INC.
Owner Details
Description:
Growth factor enhanced pharmaceutical preparations for the treatment of periodontal and cranio-maxillofacial (CMF) bone and soft tissue defects, bone and tissue defects of the head, jaw, and face and related wound healing and tissue repair;
Categories: GROWTH FACTOR ENHANCED PHARMACEUTICAL PREPARATIONS